|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/4439 | (2006.01) |
| A61K 45/06 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61P 5/28 | (2006.01) | ||
| A61P 17/14 | (2006.01) | ||
| A61K 47/10 | (2017.01) | ||
| A61K 47/34 | (2017.01) | ||
| A61K 47/44 | (2017.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61K 38/09 | (2006.01) | ||
| A61K 9/00 | (2006.01) |
| (11) | Number of the document | 2945628 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14701865.9 |
| Date of filing the European patent application | 2014-01-09 | |
| (97) | Date of publication of the European application | 2015-11-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-15 |
| (46) | Date of publication of the claims translation | 2020-05-25 |
| (86) | Number | PCT/US2014/010777 |
| Date | 2014-01-09 |
| (87) | Number | WO 2014/113260 |
| Date | 2014-07-24 |
| (30) | Number | Date | Country code |
| 201361752842 P | 2013-01-15 | US |
| (72) |
CHEN, Isan, US
HAGER, Jeffrey H., US
MANEVAL, Edna Chow, US
HERBERT, Mark R., US
SMITH, Nicholas D., US
|
| (73) |
Aragon Pharmaceuticals, Inc.,
10990 Wilshire Blvd. Suite 300, Los Angeles, CA 90024,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Androgeno receptoriaus moduliatorius derinyje su abiraterono acetatu ir prednizonu, skirtas prostatos vėžio gydymui |
| ANDROGEN RECEPTOR MODULATOR IN COMBINATION WITH ABIRATERONE ACETATE AND PREDNISONE FOR TREATING PROSTATE CANCER |
| Payment date | Validity (years) | Amount | |
| 2020-12-21 | 8 | 185.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2021-06-21 |